Highly Potent API (HPAPI), ADC Payload, and Payload-Linker Manufacturing

Our Jinshan and Changzhou sites are equipped with multiple R&D labs as well as a dedicated cGMP HP Kilo lab and plant for producing and manufacturing highly potent APIs (HPAPI's), antibody drug conjugates (ADC's), payloads, and payload-linkers. We currently offer drug product manufacturing at STA's Shanghai Waigaoqiao site and plan to extend this to our Wuxi City site as well. These facilities offer containment level down to an OEL limit of 0.05 μg/m³. Our teams have the necessary tools and expertise to serve the needs of our global clients and have a proven track record to handle your handling and manufacturing requirements.